These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 18754437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M.
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [Abstract] [Full Text] [Related]

  • 4. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY.
    Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY, Huang WW, Lin CN, Eng HL, Li SH, Li CF, Lu D, Yu SC, Hsiung CY.
    Ann Surg Oncol; 2006 Dec 20; 13(12):1633-44. PubMed ID: 17013685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z, Wang JL, Pan YL, Tao DY, Gan MF, Huang KE.
    Hepatogastroenterology; 2009 Dec 20; 56(89):149-53. PubMed ID: 19453047
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep 20; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 11. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
    Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U, Kakol M, Osuch C, Polkowski M, Głuszek S, Zurawski Z, Ruka W.
    Ann Surg Oncol; 2007 Jul 20; 14(7):2018-27. PubMed ID: 17473953
    [Abstract] [Full Text] [Related]

  • 12. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C, Lee EJ, Kim M, Lim HY, Choi DI, Noh JH, Sohn TS, Kim S, Kim MJ, Lee HK, Kim KM.
    Ann Surg; 2008 Jun 20; 247(6):1011-8. PubMed ID: 18520229
    [Abstract] [Full Text] [Related]

  • 13. [Immunomorphological characteristics and criteria for predicting gastrointestinal stromal tumors].
    Kravtsov VG, Zaĭrat'iants OV, Shirin Ch, Shakhmurov M, Shabat V, Kripshpon I, Alin A, Avinoach I, Avni J.
    Arkh Patol; 2007 Jun 20; 69(5):25-8. PubMed ID: 18074815
    [Abstract] [Full Text] [Related]

  • 14. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan YY, Chen MF.
    BMC Gastroenterol; 2006 Oct 24; 6():29. PubMed ID: 17062131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1.
    Nemoto Y, Mikami T, Hana K, Kikuchi S, Kobayashi N, Watanabe M, Okayasu I.
    Pathol Int; 2006 Dec 24; 56(12):724-31. PubMed ID: 17096729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
    Miki Y, Kurokawa Y, Hirao M, Fujitani K, Iwasa Y, Mano M, Nakamori S, Tsujinaka T.
    J Clin Gastroenterol; 2010 Feb 24; 44(2):97-101. PubMed ID: 19809358
    [Abstract] [Full Text] [Related]

  • 19. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S, Pauser U, Egberts JH, Schafmayer C, Tepel J, Fändrich F.
    Eur J Surg Oncol; 2006 Dec 24; 32(10):1125-9. PubMed ID: 16859873
    [Abstract] [Full Text] [Related]

  • 20. Prognosis of gastrointestinal stromal tumors.
    Bertin M, Angriman I, Scarpa M, Mencarelli R, Ranzato R, Ruffolo C, Polese L, Iacobone M, D'Amico DF.
    Hepatogastroenterology; 2007 Dec 24; 54(73):124-8. PubMed ID: 17419245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.